‘Amazing’ new lung cancer treatment 40% more effective than standard amid ‘golden age’ of cancer research
A new drug combo recently approved by the Food & Drug Administration can halt lung cancer in its treacherous tracks — for over 40% longer than previously possible, a wide-ranging trial funded by pharmaceutical giant Janssen showed. Doctors are hailing the breakthrough as “amazing.” Lung cancer kills roughly 1.8 million people per year. The insidious disease … Read more